Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury
The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
Deposition of amyloid beta-protein (A beta) in the brain plays a key role in the pathogenesis of Alzheimer's disease. Apolipoprotein E epsilon 4 allele (apo E-epsilon 4) is a strong risk factor for Alzheimer's disease, and there is in vitro evidence that apo E is directly involved in A beta deposition. Head injury is an epidemiological risk factor for Alzheimer's disease and deposition of A beta occurs in approximately one-third of individuals dying after a severe head injury. We report here that the frequency of apo E-epsilon 4 in those individuals with A beta deposition following head injury (0.52) is higher than in most studies of Alzheimer's disease, while in those head-injured individuals without A beta deposition the apo E-epsilon 4 frequency (0.16) is similar to controls without Alzheimer's disease (P < 0.00001). This finding provides further evidence linking apo E-epsilon 4 with A beta deposition in vivo and suggests that known environmental and genetic risk factors for Alzheimer's disease may act additively. In addition our finding indicates a genetic susceptibility to the effects of a head injury.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, a potential association between the APO E polymorphism, head injury outcome, and traumatic hematoma volume was also reported (168, 169).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [169]
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., & Ikeda, K. (1991) · Brain Research · doi:10.1016/0006-8993(91)91092-f · Cited by 1,157
Apolipoprotein E polymorphism and Alzheimer's disease
Poirier, J., Bertrand, P., Poirier, J., Kogan, S., Gauthier, S., Poirier, J., Gauthier, S., Davignon, J., Bouthillier, D., & Davignon, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91705-q · Cited by 1,108
Apolipoprotein E genotyping by one-stage PCR
Wenham, P., Price, W., & Blundell, G. (1991) · The Lancet · doi:10.1016/0140-6736(91)92823-k · Cited by 1,069
Ma, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871
Alzheimer's Disease: A Central Role for Amyloid
Selkoe, D. J. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00003 · Cited by 751
Cited by
Items 101–200 of 487
Apolipoprotein E and functional recovery from brain injury following postacute rehabilitation
Lichtman, S. W., Seliger, G., Tycko, B., & Marder, K. (2000) · Neurology · doi:10.1212/wnl.55.10.1536 · Cited by 132
ApoE immunoreactivity and microglial cells in Alzheimer’s disease brain
Uchihara, T., Duyckaerts, C., He, Y., Kobayashi, K., Seilhean, D., Amouyel, P., & Hauw, J.-J. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11763-m · Cited by 131
Prognosis in Severe Brain Injury
Stevens, R. D., & Sutter, R. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e318287ee79 · Cited by 137
APOE, APOE Promoter, and Tau Genotypes and Risk for Concussion in College Athletes
Terrell, T. R., Bostick, R. M., Abramson, R., Xie, D., Barfield, W., Cantu, R., Stanek, M., & Ewing, T. (2008) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0b013e31815c1d4c · Cited by 129
Craniocerebral Trauma: Protection and Retrieval of the Neuronal Population after Injury
Teasdale, G. M., & Graham, D. I. (1998) · Neurosurgery · doi:10.1097/00006123-199810000-00001 · Cited by 125
Self-citationCortical Cholinergic Dysfunction After Human Head Injury
MURDOCH, I., PERRY, E. K., COURT, J. A., GRAHAM, D. I., & DEWAR, D. (1998) · Journal of Neurotrauma · doi:10.1089/neu.1998.15.295 · Cited by 121
“There is increasing appreciation that the postmortem pathological correlates of a head injury share some similarity with those of Alzheimer's disease (AD) (McKen-zie et al., 1994; Roberts et al., 1994; Nicoll et al., 1995).”
Self-citationAssociation of the Estrogen Receptor α Gene Polymorphisms with Sporadic Alzheimer's Disease
Brandi, M. L., Becherini, L., Gennari, L., Racchi, M., Bianchetti, A., Nacmias, B., Sorbi, S., Mecocci, P., Senin, U., & Govoni, S. M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1665 · Cited by 136
Tsitsopoulos, P. P., & Marklund, N. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00079 · Cited by 111
“A genetic factor for AD, the ε4 allele of the lipid transport apolipoprotein E (Apoε4) seems to worsen the prognosis following TBI and predispose to the formation of Aβ plaques in AD (Nicoll et al., 1995; Kim et al., 2009).”
BackgroundInfluentialWallace, W. A., Kordi, R., Maffulli, N., & Wroble, R. R. (2009) · Springer eBooks · doi:10.1007/978-1-84800-354-5 · Cited by 130
Kehoe, P., Krawczak, M., Harper, P. S., Owen, M. J., & Jones, A. L. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.2.108 · Cited by 118
“While no sex difference in AO is observed for patients with APOE genotypes e3e3 or e3e4, the e2e3 genotype is associated with significantly earlier onset of HD in men than in women. Also, e2e3 males had significantly earlier onset than other male patients while for female patients this relationship appeared to be reve…”
Fagan, A. M., Murphy, B. A., Patel, S. N., Kilbridge, J. F., Mobley, W. C., Bu, G., & Holtzman, D. M. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6818 · Cited by 116
Apolipoprotein E Deficiency Worsens Outcome From Global Cerebral Ischemia in the Mouse
Sheng, H., Laskowitz, D. T., Mackensen, G. B., Kudo, M., Pearlstein, R. D., & Warner, D. S. (1999) · Stroke · doi:10.1161/01.str.30.5.1118 · Cited by 118
Hartman, R. E., Laurer, H., Longhi, L., Bales, K. R., Paul, S. M., McIntosh, T. K., & Holtzman, D. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10083.2002 · Cited by 115
“For example, A deposition can be found in 30% of people who die shortly after TBI (Roberts et al., 1991, 1994); a significant percentage of these patients are APOE4 (Nicoll et al., 1995, 1996).”
BackgroundApoE genotype, past adult lead exposure, and neurobehavioral function.
Stewart, W. F., Schwartz, B. S., Simon, D., Kelsey, K., & Todd, A. C. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110501 · Cited by 111
“Elevated β-amyloid deposits have been observed in humans during the acute phase of recovery from traumatic brain injury (22,23), deposits that appear more pronounced in those with the ApoE-ε4 allele (4).”
BackgroundApolipoprotein E, Amyloid, and Alzheimer Disease
Bales, K. R. (2002) · Molecular Interventions · doi:10.1124/mi.2.6.363 · Cited by 113
Casson, I. R., Viano, D. C., Haacke, E. M., Kou, Z., & LeStrange, D. G. (2014) · Sports Health: A Multidisciplinary Approach · doi:10.1177/1941738114540270 · Cited by 103
Weiner, M. W., Harvey, D., Hayes, J., Landau, S. M., Aisen, P. S., Petersen, R. C., Tosun, D., Veitch, D. P., Jack, C. R., Decarli, C., et al. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.02.005 · Cited by 107
Apolipoprotein E: Implications for AD neurobiology, epidemiology and risk assessment
Schipper, H. M. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.021 · Cited by 121
Gentleman, S. M., Greenberg, B. D., Savage, M. J., Noori, M., Newman, S. J., Roberts, G. W., Griffin, W. S. T., & Graham, D. I. (1997) · NeuroReport · doi:10.1097/00001756-199704140-00039 · Cited by 110
Self-citationApolipoprotein E Expression by Neurons Surviving Excitotoxic Stress
Boschert, U., Merlo-Pich, E., Higgins, G., Roses, A. D., & Catsicas, S. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0251 · Cited by 109
Pharmacogenomics in Alzheimer's Disease
Cacabelos, R. (2008) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-205-2_10 · Cited by 109
Cognitive functions in low-grade gliomas: disease and treatment effects
Correa, D. D., DeAngelis, L. M., Shi, W., Thaler, H. T., Lin, M., & Abrey, L. E. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9212-3 · Cited by 117
Possible Causes of Alzheimer's Disease: Amyloid Fragments, Free Radicals, and Calcium Homeostasis
Hölscher, C. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0193 · Cited by 102
Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils
Hatters, D. M., Zhong, N., Rutenber, E., & Weisgraber, K. H. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.06.080 · Cited by 105
Genetics of Alzheimer's Disease. A Rapidly Evolving Field
Serretti, A., Olgiati, P., & De Ronchi, D. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-12108 · Cited by 103
“177]; 2) APOE ε4 allele is associated with deposition of amyloid-β protein following head injury [178]; 3) a 10-fold increase in risk of developing AD has been reported in individuals with APOE ε4 and a history of traumatic head injury compared to a twofold increase in risk with APOE ε4 alone [179].”
Hejmadi, M. V., Dajas‐Bailador, F., Barns, S. M., Jones, B. J., & Wonnacott, S. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00244-6 · Cited by 105
Sports Concussion and the Risk of Chronic Neurological Impairment
McCrory, P. (2011) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0b013e318204db50 · Cited by 104
Raymont, V., Greathouse, A., Reding, K., Lipsky, R., Salazar, A., & Grafman, J. (2008) · Brain · doi:10.1093/brain/awm300 · Cited by 101
“Ab deposition can be found in $30% of people who die shortly after CHI (Roberts et al., 1991), and a significant percentage of these patients are APO e4 positive (Nicoll et al., 1995, 1996; Teasdale et al., 1997; Lichtman et al., 2000).”
BackgroundPonsford, J., McLaren, A., Schönberger, M., Burke, R., Rudzki, D., Olver, J., & Ponsford, M. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1623 · Cited by 103
“The findings from other studies in relation to this likelihood have been mixed (Guo et al., 2000; Isoniemi et al., 2006; Mayeux et al., 1995; Mehta et al., 1999; Nicoll et al., 1995; O’Meara et al., 1997; Raymont et al., 2008).”
ResultWashington, P. M., Morffy, N., Parsadanian, M., Zapple, D. N., & Burns, M. P. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3017 · Cited by 103
MURAKAMI, N., YAMAKI, T., IWAMOTO, Y., SAKAKIBARA, T., KOBORI, N., FUSHIKI, S., & UEDA, S. (1998) · Journal of Neurotrauma · doi:10.1089/neu.1998.15.993 · Cited by 100
“…posited that traumatic brain injury is an epidemiological risk factor for Alzheimer disease (Mortimer et al., 1991; Mayeux et al., 1993; Schofield et al., 1997), although other genetic factors, which include the apoE genotype, might act additively (Nicoll et al., 1995, 1996; O'Meara et al., 1997).”
Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice
Hamanaka, H. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.3.353 · Cited by 95
“More recent studies on experimental ischemia (61), head injury in humans (62) and brain lesions in apoE-deficient mice (63) further support the idea that apoE plays a part in neural repair processes.”
McFadyen, C. A., Zeiler, F. A., Newcombe, V., Synnot, A., Steyerberg, E., Gruen, R. L., Rosand, J., Palotie, A., Maas, A. I. R., & Menon, D. K. (2021) · Journal of Neurotrauma · doi:10.1089/neu.2018.6052 · Cited by 90
Sleep apnea, APOE4 and Alzheimer's disease 20 years and counting?
Bliwise, D. L. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00436-1 · Cited by 102
Alzheimer’s Disease and Cholesterol: The Fat Connection
Canevari, L., & Clark, J. B. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9200-1 · Cited by 108
Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E
Nathoo, N. (2003) · Molecular Pathology · doi:10.1136/mp.56.3.132 · Cited by 97
Association between apolipoprotein E genotype and outcome of traumatic brain injury
Chiang, M.-F., Chang, J., & Hu, C. (2003) · Acta Neurochirurgica · doi:10.1007/s00701-003-0069-3 · Cited by 105
“determining a genetic susceptibility to the effects of a traumatic brain injury (Table 3) [10, 11, 20, 28, 30].”
BackgroundInfluentialProfessional Fighters Brain Health Study: Rationale and Methods
Bernick, C. B., Banks, S. J., Phillips, M., Lowe, M. J., Shin, W., Obuchowski, N. A., Jones, S., & Modic, M. T. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws456 · Cited by 97
Onset of dementia is associated with apolipoprotein E ε4 in Down's syndrome
Schupf, N., Lee, J. H., Kapell, D., Zigman, W., Canto, B., Tycko, B., & Mayeux, R. (1996) · Annals of Neurology · doi:10.1002/ana.410400518 · Cited by 91
Brain injury-induced dysfunction of the blood brain barrier as a risk for dementia
Abrahamson, E. E., & Ikonomovic, M. D. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113257 · Cited by 86
Kristman, V. L., Tator, C. H., Kreiger, N., Richards, D. W., Mainwaring, L. M., Jaglal, S. B., TOMLINSON, G. A., & Comper, P. (2008) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0b013e31817e6f3e · Cited by 100
Laskowitz, D. T., Song, P., Wang, H., Mace, B., Sullivan, P. M., Vitek, M. P., & Dawson, H. N. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1396 · Cited by 92
“APOE4 is associated with increased susceptibility of developing late-onset familial and sporadic AD (Corder et al., 1993), and is also associated with increased deposition of A b in the setting of acute brain injury (Nicoll et al., 1995) and neurodegenerative disease (Schmechel et al., 1993).”
Brain Trauma in Aged Transgenic Mice Induces Regression of Established Aβ Deposits
Nakagawa, Y., Reed, L., Nakamura, M., McIntosh, T. K., Smith, D. H., Saatman, K. E., Raghupathi, R., Clemens, J., Saido, T. C., Lee, V. M.-Y., et al. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7375 · Cited by 91
The role of apolipoprotein E in Alzheimer’s disease: pharmacogenomic target selection
Saunders, A. M., Trowers, M. K., Shimkets, R. A., Blakemore, S., Crowther, D. J., Mansfield, T. A., Wallace, D. M., Strittmatter, W. J., & Roses, A. D. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00035-1 · Cited by 93
β‐Amyloid (Aβ)42(43), Aβ42, Aβ40 and apoE immunostaining of plaques in fatal head injury
Horsburgh, K., Cole, G. M., Yang, F., Savage, M. J., Greenberg, B. D., Gentleman, S. M., Graham, D. I., & Nicoll, J. A. R. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.026002124.x · Cited by 88
Self-citationAn overview of the genes and biomarkers in Alzheimer’s disease
Krishnamurthy, H. K., Jayaraman, V., Krishna, K., Wang, T., Bei, K., Changalath, C., & Rajasekaran, J. J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102599 · Cited by 98
“This allele is also associated with earlier onset of AD (Liu, et al., 2002) and worse outcomes after stroke (Nicoll, et al., 1995) and head trauma (Mahley and Rall, 1999).”
Lawrence, D. W., Comper, P., Hutchison, M. G., & Sharma, B. (2015) · Brain Injury · doi:10.3109/02699052.2015.1005131 · Cited by 82
Kiràly, M. A., & Kiraly, S. J. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.269 · Cited by 99
McCarron, M. O., & Nicoll, J. A. R. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00286-9 · Cited by 88
Self-citationMcCrory, P. R., Johnston, K., Meeuwisse, W. H., Aubry, M., Cantu, R. C., Dvořák, J., Graf-Baumann, T., Kelly, J. P., Lovell, M. R., & Schamasch, P. (2005) · The Physician and Sportsmedicine · doi:10.3810/psm.2005.04.76 · Cited by 87
The impact of age on traumatic brain injury
Flanagan, S. R., Hibbard, M. R., & Gordon, W. A. (2005) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2004.06.012 · Cited by 94
Amyloid myopathy: An underdiagnosed entity
Spuler, S., Emslie‐Smith, A. M., & Engel, A. G. (1998) · Annals of Neurology · doi:10.1002/ana.410430606 · Cited by 89
Jellinger, K. A., Paulus, W., Wrocklage, C., & Litvan, I. (2001) · BMC Neurology · doi:10.1186/1471-2377-1-3 · Cited by 86
“Although it is well established that deposition of amyloid β peptide (Aβ) known to play an important role in the pathogenesis of AD, in fatal TBI is associated with an ApoEe4 allele [ 10 ,11] and that TBI may induce tau pathology with the formation of neurofibrillary tangles, another major histological marker of AD [1…”
BackgroundIncreased apolipoprotein E ϵ4 in epilepsy with senile plaques
Gouras, G. K., Relkin, N. R., Sweeney, D., Munoz, D. G., Mackenzie, I. R., & Gandy, S. (1997) · Annals of Neurology · doi:10.1002/ana.410410317 · Cited by 71
Apolipoprotein E Genotype and Cognitive Dysfunction after Noncardiac Surgery
Abildstrøm, H., Christiansen, M., Siersma, V., & Rasmussen, L. S. (2004) · Anesthesiology · doi:10.1097/00000542-200410000-00009 · Cited by 86
“The 4 allele is associated with increased risk for atherosclerosis(3) and Alzheimer disease, reduced neurite outgrowth,(7) and poor prognosis after cerebral injury.(8,9) There are data to indicate that presence of the 4 allele may predict accelerated cognitive decline within a normal aging population.”
BackgroundApolipoprotein E, a Gene with Complex Biological Interactions in the Aging Brain
Roses, A. D. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0161 · Cited by 87
Hölscher, C. (2005) · Reviews in the Neurosciences · doi:10.1515/revneuro.2005.16.3.181 · Cited by 82
The role of APOE polymorphisms in late-onset dementias
Corder, E. H., Lannfelt, L., Bogdanović, N., Fratiglioni, L., & Mori, H. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050223 · Cited by 91
Horsburgh, K., & Nicoll, J. A. R. (1996) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1996.tb01113.x · Cited by 84
Self-citationWeiner, M. W., Veitch, D. P., Hayes, J., Neylan, T., Grafman, J., Aisen, P. S., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.04.005 · Cited by 78
ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-β1–42
Trommer, B. L., Shah, C., Yun, S. H., Gamkrelidze, G., Pasternak, E. S., Blaine Stine, W., Manelli, A., Sullivan, P., Pasternak, J. F., & LaDu, M. J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.08.011 · Cited by 82
“…well as other clinical disorders that involve amyloid (e.g., cerebral amyloid angiopathy), apoE4 is associated with increased amyloid deposi- tion compared with apoE3 (Deb et al., 2000; Greenberg et al., 1998; Jordan et al., 1997; Nicoll et al., 1995; Polvikoski et al., 1995; Rebeck et al., 1993).”
Apolipoprotein E4 as a Predictor of Outcomes in Pediatric Mild Traumatic Brain Injury
Moran, L. M., Taylor, H. G., Ganesalingam, K., Gastier-Foster, J. M., Frick, J., Bangert, B., Dietrich, A., Nuss, K. E., Rusin, J., Wright, M., et al. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0767 · Cited by 82
“Studies have suggested that possession of the APOE e 4 allele is associated with more severe injuries (Liaquat et al., 2002; Nicoll et al., 1995; Teasdale et al., 1997) and possibly with a greater risk of neurological deterioration (Jiang et al., 2006).”
Expression of amyloid precursor protein after rat traumatic brain injury
Itoh, T., Satou, T., Nishida, S., Tsubaki, M., Hashimoto, S., & Ito, H. (2009) · Neurological Research · doi:10.1179/016164108x323771 · Cited by 78
Ancelin, M., de Roquefeuil, G., Scali, J., Bonnel, F., Adam, J. J., Cheminal, J.-C., Cristol, J., Dupuy, A., Carrière, I., & Ritchie, K. A. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100807 · Cited by 86
Tanriverdi, F., Taheri, S., Ulutabanca, H., Caglayan, A. O., Ozkul, Y., Dundar, M., Selcuklu, A., Unluhizarci, K., Casanueva, F. F., & Kelestimur, F. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2007.0456 · Cited by 77
“Nicoll et al. (1995) demonstrated the potential association of APO E polymorphism with head injury outcome.”
Heegaard, W. G., & Biros, M. H. (2007) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2007.07.001 · Cited by 109
Maxwell, W. L., Pennington, K., MacKinnon, M. A., Smith, D. H., McIntosh, T. K., Wilson, J. T. L., & Graham, D. I. (2004) · Brain · doi:10.1093/brain/awh294 · Cited by 83
“…clinical studies suggest that TBI may accelerate or exacerbate cognitive decline associated with normal ageing (Stuss et al., 1989) and induce Alzheimer’s disease-like neurodegeneration (Mortimer et al., 1991; Gentleman et al., 1993; Mayeux et al., 1993; Nicoll et al., 1995; Geddes et al., 1996).”
BackgroundRoses, A. D. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80098-5 · Cited by 82
Mulder, M., Blokland, A., van den Berg, D.-J., Schulten, H., Bakker, A. H. F., Terwel, D., Honig, W., de Kloet, E. R., Havekes, L. M., Steinbusch, H. W. M., et al. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780307 · Cited by 74
“ApoE4 has also been associated with other neurological dis- eases, including vascular dementia and a poor clinical outcome in patients after stroke and head injury (Nicoll et al, 1995; Slooter et al, 1997).”
BackgroundMagnoni, S., & Brody, D. L. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.214 · Cited by 72
In vivo detection of cerebral tau pathology in long-term survivors of traumatic brain injury
Gorgoraptis, N., Li, L. M., Whittington, A., Zimmerman, K. A., Maclean, L. M., McLeod, C., Ross, E., Heslegrave, A., Zetterberg, H., Passchier, J., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1993 · Cited by 75
“In keeping with these findings, Aβ plaque pathology following TBI is more prevalent in individuals with at least one APOE ε4 allele (57).”
BackgroundNicoll, J. A. R., Burnett, C., Love, S., Graham, D. I., Ironside, J. W., & Vinters, H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390521 · Cited by 74
Self-citationApolipoprotein E Polymorphism: Survival and Neurological Outcome After Cardiopulmonary Resuscitation
Schiefermeier, M., Kollegger, H., Madl, C., Schwarz, C., Holzer, M., Kofler, J., & Sterz, F. (2000) · Stroke · doi:10.1161/01.str.31.9.2068 · Cited by 72
Smith, M. E., van der Maesen, K., & Somera, F. P. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981001)54:1<68::aid-jnr8>3.0.co;2-f · Cited by 160
ApoE, Alzheimer's Disease, and Recovery from Brain Stressa
ROSES, A. D., & SAUNDERS, A. M. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48471.x · Cited by 73
Nathoo, N., Chetty, R., van Dellen, J. R., Connolly, C., & Naidoo, R. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.98.2.0302 · Cited by 72
Ito, J., Zhang, L., Asai, M., & Yokoyama, S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722362.x · Cited by 70
“…factor for Alzheimer’s disease (Corder et al., 1993; Poirier et al., 1993; Strittmatter et al., 1993; Nathan et al., 1994; Roses et al., 1994) and for the deposition of amyloidb protein after head injury (Nicoll et al., 1995; Jordan et al., 1997) or intracranial hemorrhage (Alberts et al., 1995).”
BackgroundDiagnosis and Staging of Alzheimer Disease
Duyckaerts, C. J., & Hauw, J. J. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00067-5 · Cited by 72
A Neprilysin Polymorphism and Amyloid-β Plaques Following Traumatic Brain Injury
Johnson, V. E., Stewart, W. B., Jr., Stewart, J. E., Graham, D. I., Praestgaard, A. H., & Smith, D. H. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008-0843 · Cited by 72
Self-citationThe role of apolipoprotein E in lipid metabolism in the central nervous system
Han, X. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4009-z · Cited by 71
Prospective Study of Apolipoprotein E Genotype and Functional Outcome Following Ischemic Stroke
McCarron, M. O., Muir, K. W., Nicoll, J. A. R., Stewart, J., Currie, Y., Brown, K., & Bone, I. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1480 · Cited by 72
Self-citationNiskakangas, T., Öhman, J. E., Niemela, M. R., Ilveskoski, E., Kunnas, T. A., & Karhunen, P. J. (2001) · Stroke · doi:10.1161/01.str.32.5.1181 · Cited by 72
“2 29 (43) 13 (33) 0.095 3 6 (9) 7 ( 18 ) 0.069”
Influential4‐Hydroxynonenal Immunoreactivity is Increased in Human Hippocampus After Global Ischemia
McCracken, E., Graham, D. I., Nilsen, M., Stewart, J., Nicoll, J. A., & Horsburgh, K. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00409.x · Cited by 68
Self-citationHorsburgh, K., McCulloch, J., Nilsen, M., Roses, A. D., & Nicoll, J. A. R. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.01339.x · Cited by 70
“More recently, the APOE-e4 allele has been shown to be associated with a poorer outcome after acute brain damage, including that due to head injury (Nicoll et al., 1995; Teasdale et al., 1997; Friedman et al., 1999), spontaneous intracerebral haemorrhage (Alberts et al., 1995; McCarron et al.,…”
BackgroundSelf-citationAtwood, C., Bowen, R. L., Smith, M. A., & Perry, G. L. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00206-6 · Cited by 76
Apolipoprotein E and the Response of the Brain to Injury
Graham, D. I., Horsburgh, K. J., Nicoll, J. A. R., & Teasdale, G. M. (1999) · Acta neurochirurgica. Supplementum · doi:10.1007/978-3-7091-6391-7_15 · Cited by 72
Self-citationThe generation and function of soluble apoE receptors in the CNS
Rebeck, G. W., LaDu, M. J., Estus, S., Bu, G., & Weeber, E. J. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-15 · Cited by 66
Outcome following traumatic brain injury in the elderly: a critical review
Rapoport, A. F. M. J. (2000) · Brain Injury · doi:10.1080/026990500413777 · Cited by 69
The effects of APOE genotype on age at onset and progression of neurodegenerative diseases
Chapman, J., Korczyn, A. D., Karussis, D. M., & Michaelson, D. M. (2001) · Neurology · doi:10.1212/wnl.57.8.1482 · Cited by 67
Horsburgh, K., McCulloch, J., Nilsen, M., McCracken, E., Large, C., Roses, A. D., & Nicoll, J. A. R. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00003 · Cited by 67
“It is unclear as yet whether patients with APOE E4 have a poorer outcome after brain injury (Alberts et al., 1995; Jordan et al., 1997; Nicoll et al., 1995; Teasdale et al., 1997) because of reduced levels of apoE or because of apoE isoform-specific effects.”
BackgroundSelf-citationWang, H., Durham, L., Dawson, H. N., Song, P., Warner, D. S., Sullivan, P. M., Vitek, M. P., & Laskowitz, D. T. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.017 · Cited by 68
The Role of Apolipoprotein E in Cognitive Decline and Delirium after Bypass Heart Operations
Tagarakis, G. I., Tsolaki-Tagaraki, F., Tsolaki, M., Diegeler, A., Tsilimingas, N. B., & Papassotiropoulos, A. (2007) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317507299415 · Cited by 65
Fall‐related brain injuries and the risk of dementia in elderly people: a population‐based study
Luukinen, H., Viramo, P., Herala, M., Kervinen, K., Kesäniemi, Y. A., Savola, O., Winqvist, S., Jokelainen, J., & Hillbom, M. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00953.x · Cited by 63
“2005 EFNS European Journal of Neurology 12, 86–92 Nicoll et al. (1995) found that carriers of the ApoE e4 allele were overrepresented amongst those who died after head injury and had b-amyloid deposits.”
BackgroundThe structural basis of moderate disability after traumatic brain damage
ADAMS, J. H., Graham, D. I., & Jennett, B. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.4.521 · Cited by 71
“If a head injury does precipitate Alzheimer's disease then a potent acute phase molecule such as IL1 and the upregulation of neuronal β-APP are necessarily involved”
BackgroundKay, A. D., Petzold, A., Kerr, M., Keir, G., Thompson, E., & Nicoll, J. A. R. (2003) · Journal of Neurotrauma · doi:10.1089/089771503770195795 · Cited by 63
“…A b deposition in the cerebral cortex of patients who die soon after TBI, and less favourable outcome in survivors of a variety of different types of acute brain injury (McCarron et al., 2000; Nicoll et al., 1995; Niskakangas et al., 2001; Schiefermeier et al., 2000; Teasdale et al., 1997).”
Self-citationTraumatic brain injury: future assessment tools and treatment prospects
Flanagan, S. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1985 · Cited by 61
“…it is speculated to adversely effect processes involved in cellular membrane maintenance and repair (Mahley 1988; Weisgraber et al 1994), calcium metabolism (Veinbergs et al 2002), neural plasticity (Mauch et al 2001; Nathan et al 1994), and increased amyloid plaque deposition (Nicoll et al 1995).”
BackgroundApolipoprotein E and brain injury: implications for children
Blackman, J. A., Worley, G., & Strittmatter, W. J. (2005) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162205000113 · Cited by 66
Outcome After Traumatic Brain Injury Sustained in Older Adulthood: A One-Year Longitudinal Study
Rapoport, M. J., Herrmann, N., Shammi, P., Kiss, A., Phillips, A., & Feinstein, A. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000199339.79689.8a · Cited by 70
Cao, J., Gaamouch, F. E., Meabon, J. S., Meeker, K. D., Zhu, L., Zhong, M. B., Bendik, J., Elder, G., Jing, P., Xia, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11654-7 · Cited by 62
Aging, Neurodegenerative Disease, and Traumatic Brain Injury: The Role of Neuroimaging
Esopenko, C., & Levine, B. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2014.3506 · Cited by 63
Metadata
- Authors
- Nicoll, J. A. R., Roberts, G. W., & Graham, D. I.
- Affiliations
- Southern General Hospital (GB)
- Venue
- Nature Medicine
- Published
- 1995-02
- Volume
- 1
- Issue
- 2
- Pages
- 135-137
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1972243699
- Cited by
- 486
- References
- 25
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 9 · 2019: 12 · 2018: 4 · 2017: 8 · 2016: 8 · 2015: 13 · 2014: 10 · 2013: 14 · 2012: 6
- FWCI
- 21.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Keywords
- APOE ε4, traumatic brain injury, Alzheimer's disease, genetic susceptibility, risk factors, genetic risk factors, environmental risk factors
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Alleles, Alzheimer Disease, Apolipoproteins E, Cerebral Cortex, Gene Frequency, Craniocerebral Trauma, Humans, Middle Aged, Risk Factors, Amyloid beta-Peptides, Gene Dosage, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.